MedPath

"A Clinical Study of Alambushadi Churna and Shatyadi Kashay in patients of Amvata vis a vis Rheumatoid Arthritis"

Phase 2/3
Not yet recruiting
Conditions
Other disorders of the musculoskeletal system and connective tissue. Ayurveda Condition: Amvata,
Registration Number
CTRI/2022/02/040534
Lead Sponsor
Department of Kayachikitsa Shri Krishna Ayush University Kurukshetra Haryana
Brief Summary

A Randomized parallel trial with title " A Clinical Study Of Alambushadi churna and Shatyadi Kashay in patients of Amvata vis-a-vis Rheumatoid Arthritis" in which 100 patients will be taken under 2 groups. Group A consists of Alambushadi Churna 5 gms with lukewarm water  BD for 45 days .Group B contains Alambushadi Churna  5gm BD and Shatyadi Kashay 40 ml BD for 45 days. Follow up period is of 15 days.The components of Alambushadi  Churna are Alambusha Gokshura Haritaki Bhibhitak Amlaki Shunthi Amrita and Shyama root.  Shatyadi Kashay consists of Shati Shunthi Ativisha Vacha Devdaru Guduchi in equal parts. Patient assessment will be done on the basis of subjective and objective criteria and diagnosis according to EULAR criteria.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patients of age group between 30-50 years willing to participate for the trial with a diagnosis of rheumatoid arthritis using theEULAR diagnostic criteria Diagnosed cases of Amavata based on symptoms and signs described in MadhavNidana.
  • Seropositive and Seronegative both cases are included.
  • Having history of less than 5 years.
Exclusion Criteria
  • Patients not willing to participate.
  • Patients having severe deformities.
  • Patients of Gouty Arthritis, Infective Arthritis, Osteoarthritis.
  • HIV, Tuberculosis, Hypertension, D.M., and other major systemic problems.
  • Pregnant & lactating women 6.Patients with major complications such as extra articular manifestations like leg ulcers, digital gangrene, Episcleritis, Endocarditis, pleural and pericardial effusions, neurological and haematologic manifestations etc.
  • will also be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ï‚·Both the drugs of the study are expected to be effective because these are mentioned specifically in Amvataprakran in classical text and all constituents are having properties opposite to Ama dosha Vedanashamak and Shothhara45 days
Secondary Outcome Measures
NameTimeMethod
ï‚·there can be significant reduction in modern objective parameters like RA factor Anti CCP CRP So effect of Ayurvedic text formulations on Modern parameters can be proved by the study45 days

Trial Locations

Locations (1)

MLR ayurveda college and Hospital

🇮🇳

Bhiwani, HARYANA, India

MLR ayurveda college and Hospital
🇮🇳Bhiwani, HARYANA, India
Dr Priyanka yadav
Principal investigator
7054236800
pinkdeep55@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.